Executive summary
Carle Health’s CDI team wasn’t immune to overarching industry pressures from the increasing volume of patient data to review, along with the growing complexity of clinical and coding requirements. Knowing their program was leaving some revenue behind, despite their best efforts, they turned to SmarterPrebill’s™ clinical AI to help surface opportunities that human review alone could not.
Read the Carle Health x SmarterDx case study to learn:
- How Carle Health realized $19.5M in revenue impact across ~12,000 encounters
- The key reasons that lead the Carle Health team to choose SmarterPrebill
- About Carle Health’s plans to expand their clinical AI use into the denials space with SmarterDenials™
What changed operationally
Result methodology and context
